Ratios in Focus: Analyzing Sarepta Therapeutics Inc (SRPT)’s Price-to-Cash and Price-to-Free Cash Flow

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

In the latest session, Sarepta Therapeutics Inc (NASDAQ: SRPT) closed at $132.58 down -2.54% from its previous closing price of $136.04. In other words, the price has decreased by -$2.54 from its previous closing price. On the day, 1.57 million shares were traded. SRPT stock price reached its highest trading level at $137.14 during the session, while it also had its lowest trading level at $129.47.


For a deeper understanding of Sarepta Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 4.05. In the meantime, Its Debt-to-Equity ratio is 1.44 whereas as Long-Term Debt/Eq ratio is at 1.33.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on January 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $170.

On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $109.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $109 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 02 ’24 when Murray Dallan sold 3,635 shares for $140.00 per share. The transaction valued at 508,900 led to the insider holds 18,125 shares of the business.

Boor Kathryn Jean sold 761 shares of SRPT for $93,550 on Mar 11 ’24. The Director now owns 7,516 shares after completing the transaction at $122.93 per share. On Mar 08 ’24, another insider, Wigzell Hans Lennart Rudolf, who serves as the Director of the company, sold 15,000 shares for $123.25 each. As a result, the insider received 1,848,795 and left with 22,840 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 12531965952 and an Enterprise Value of 12863888384. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1993.68, and their Forward P/E ratio for the next fiscal year is 13.28. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.93 while its Price-to-Book (P/B) ratio in mrq is 13.03. Its current Enterprise Value per Revenue stands at 9.167 whereas that against EBITDA is -242.738.

Stock Price History:

Over the past 52 weeks, SRPT has reached a high of $159.89, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is 5.46%, while the 200-Day Moving Average is calculated to be 17.84%.

Shares Statistics:

For the past three months, SRPT has traded an average of 900.77K shares per day and 1400140 over the past ten days. A total of 93.73M shares are outstanding, with a floating share count of 88.89M. Insiders hold about 5.96% of the company’s shares, while institutions hold 85.90% stake in the company. Shares short for SRPT as of 1713139200 were 4874305 with a Short Ratio of 5.41, compared to 1710460800 on 4966633. Therefore, it implies a Short% of Shares Outstanding of 4874305 and a Short% of Float of 5.390000000000001.

Most Popular

[the_ad id="945"]